P

Inventor

FREYNE EDDY JEAN EDGARD

BE50 patents
⚠️ This page may combine multiple inventors who share the name “FREYNE EDDY JEAN EDGARD”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

JANSSEN PHARMACEUTICA NV

26 patents
US7514445B2Apr 7, 2009

Heteroaryl amines as glycogen synthase kinase 3β inhibitors (GSK3 inhibitors)

JANSSEN PHARMACEUTICA NV117 citations97
US7799772B2Sep 21, 2010

Pyrido-and pyrimidopyrimidine derivatives as anti-profilerative agents

JANSSEN PHARMACEUTICA NV16 citations92
US6583141B1Jun 24, 2003

4,5-dihydro-isoxazole derivatives and their pharmaceutical use

JANSSEN PHARMACEUTICA NV18 citations89
US6403805B1Jun 11, 2002

1,3-dihydro-1-(phenylalkyl)-2H-imidazol-2-one derivatves

JANSSEN PHARMACEUTICA NV20 citations87
US7648975B2Jan 19, 2010

Macrocyclic quinazoline derivatives as antiproliferative agents

JANSSEN PHARMACEUTICA NV12 citations83
US7560458B2Jul 14, 2009

Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors

JANSSEN PHARMACEUTICA NV9 citations83
US5994376ANov 30, 1999

1,3-dihydro-1-(phenylalkyl)-2H-imidazol-2-one compounds and their use for treating allergic, atopic or inflammatory diseases

JANSSEN PHARMACEUTICA NV17 citations83
US7655642B2Feb 2, 2010

3-cyano-quinoline derivatives with antiproliferative activity

JANSSEN PHARMACEUTICA NV13 citations82
US7449465B2Nov 11, 2008

Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors

JANSSEN PHARMACEUTICA NV12 citations82
US6051718AApr 18, 2000

PDE IV inhibiting 2-cyanoiminoimidazole derivatives

JANSSEN PHARMACEUTICA NV15 citations71
US5952510ASep 14, 1999

1,3-dihydro-1-(phenylalkenyl)-2H-imidazol-2-one derivatives having PDE IV and cytokine inhibiting activity

JANSSEN PHARMACEUTICA NV3 citations61
US5869515AFeb 9, 1999

1,3-dihydro-2H-imidazol-2-one compounds

JANSSEN PHARMACEUTICA NV5 citations61
US7947695B2May 24, 2011

5-membered annelated heterocyclic pyrimidines as kinase inhibitors

JANSSEN PHARMACEUTICA NV4 citations60
US7947694B2May 24, 2011

Substituted pyrazolo[3,4-D]pyrimidines as cell cycle kinase inhibitors

JANSSEN PHARMACEUTICA NV2 citations60
US6803364B1Oct 12, 2004

Il-5 inhibiting 6-azauracil derivatives

JANSSEN PHARMACEUTICA NV2 citations60
US7241763B2Jul 10, 2007

3-furanyl analogs of toxoflavine as kinase inhibitors

JANSSEN PHARMACEUTICA NV2 citations57
US10208062B2Feb 19, 2019

Macrocyclic quinazole derivatives and their use as MTKI

JANSSEN PHARMACEUTICA NV0 citations51
US9688691B2Jun 27, 2017

Macrocyclic quinazole derivatives and their use as MTKI

JANSSEN PHARMACEUTICA NV0 citations51
US9365517B2Jun 14, 2016

3-cyano-quinoline derivatives with antiproliferative activity

JANSSEN PHARMACEUTICA NV0 citations51
US9273013B2Mar 1, 2016

Quinazoline derivatives

JANSSEN PHARMACEUTICA NV0 citations51
US9040511B2May 26, 2015

3-cyano-quinoline derivatives with antiproliferative activity

JANSSEN PHARMACEUTICA NV0 citations51
US7414048B2Aug 19, 2008

4,5-dihydro-isoxazole derivatives and their pharmaceutical use

JANSSEN PHARMACEUTICA NV0 citations48
US6743792B2Jun 1, 2004

6-azauracil derivatives as IL-5 inhibitors

JANSSEN PHARMACEUTICA NV1 citations47
US6894046B2May 17, 2005

IL-5 inhibiting 6-azauracil derivatives

JANSSEN PHARMACEUTICA NV0 citations41
US6867207B2Mar 15, 2005

IL-5 inhibiting 6-azauracil derivatives

JANSSEN PHARMACEUTICA NV0 citations41
US6498158B1Dec 24, 2002

Il-5 inhibiting 6-azauracil derivatives

JANSSEN PHARMACEUTICA NV0 citations35

FREYNE EDDY JEAN EDGARD

9 patents

ASTEX THERAPEUTICS LTD

3 patents

SAXTY GORDON

3 patents

VIALARD JORGE EDUARDO

2 patents

JANSSEN CILAG S A

1 patent

JANNSEN CILAG S A

1 patent

JANSSEN PHARMACEUTICS N V

1 patent

BERDINI VALERIO

1 patent

(unassigned)

1 patent

PAPANIKOS ALEXANDRA

1 patent

DIELS GASTON STANISLAS MARCELLA

1 patent